Basf announces it’s performance forecast in 2023
On January 19, BASF released preliminary data for the full year 2023.
In 2023, BASF's sales are expected to be 68.902 billion euros, about 539.302 billion yuan, down 21.1% year-on-year; Earnings before interest and tax (EBIT) before special items was 3.806 billion euros, about 29.79 billion yuan, down 44.66% year-on-year; Net profit is expected to reach 225 million euros, about 1.761 billion yuan, an increase of 135.89%.
The official report will be released on February 23, 2024 CET.
Basf mentioned in the trailer:
EBIT for Industrial Solutions, Materials and Agriculture solutions was slightly above the average analyst estimate;
▪ In the chemicals segment, EBIT was well below the average analyst estimate. Mainly caused by unplanned factory closure and other reasons;
In surface technology and Nutrition and care, EBIT was slightly below analyst consensus;
▪ Elsewhere, EBIT was slightly below the average analyst estimate.
Overall, BASF's performance in 2023 fell short of expectations. Earnings fell sharply, mostly because soaring energy bills offset cost cuts and put pressure on production at Europe's largest chemicals company.
At present, BASF has taken a number of measures to deal with the decline in earnings and weak economic growth in its European home market, including the appointment of the experienced Marcus Kelley as the new chief executive officer, and the reduction of investment in the next few years by 4 billion euros.
2026-10-14
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
ACE will be held during 14-16,Oct.,2026. There are detailed information about ACE.
-
BASF and Evonik Rumored Potential Acquisition or Merger
-
BASF and Thailand’s NEO Corporate Enter Joint Development Partnership in Personal Care
-
BASF Raises North American Nylon Products by $0.08/lb, Fourth Price Increase in Six Months
-
Renaissance BioScience Receives Genome BC Funding to Extend RNAi Biopesticide Platform to Target Soil-Dwelling Crop Pests
-
Renaissance BioScience Receives Genome BC Funding to Extend RNAi Biopesticide Platform to Target Soil-Dwelling Crop Pests
-
First New UV Filter in Nearly 27 Years: BASF's Tinosorb® S Approved by FDA, Marking a Historic Shift for the U.S. Sunscreen Market
-
Multiple Chemical Industry Leaders Post Strong H1 Earnings Growth as Sector Profitability Revives
-
The Crop Protection Patent Cliff Is Here
-
BASF's Intensified Moves from May to June: Plant Closures, Divestitures, and Transformation in Sync
Recommend Reading
-
Titanium Dioxide: Stuck Between Weak Upside and Limited Downside
-
Supply Chain Resilience Reshapes Chemical Competition: What Lies Behind BASF’s Stable Outlook
-
Kering and L'Oréal Form $4 Billion Strategic Alliance in Luxury Beauty and Wellness
-
Wanhua Chemical Establishes a RMB 1.488 Billion New Energy Materials Company in Weifang, Further Integrating Green Power and Battery Materials Businesses
-
Pregabalin vs Gabapentin: Differences, Uses, and Side Effects
-
Insufficient downstream demand for DMF leads to a generally narrow and weak market performance
-
Weakness in China's Methanol Market Continues in November
-
Insufficient Cost Support Leads to Wide-Ranging Decline in Acrylic Market
-
September Isooctanol Prices in China Surge Before Declining
-
BDO Market Conditions Remain Weak
- Hot Searches
- 5 aminolevulinic acid price
- reta weight loss where to buy
- retatrutide 20mg where to buy
- methyl acrylate sds
- semaglutide research peptide for sale
- methyl acetate liquid
- 2 methylacetanilide
- potassium chloride price
- ethylhexyl glycerin
- reta for sale
- sodium sulphate anhydrous price
- agranulocytosis vs leukopenia